아미노글리코사이드 시장 규모, 점유율 및 성장 분석 : 약제 유형별, 투여 경로별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Aminoglycosides Market size was valued at USD 1.6 Billion in 2024 and is poised to grow from USD 1.67 Billion in 2025 to USD 2.34 Billion by 2033, growing at a CAGR of 4.3% during the forecast period (2026-2033).

The global aminoglycosides market is driven by the critical need for effective antibiotics, particularly for treating severe Gram-negative infections. Key products like gentamicin, amikacin, and tobramycin are favored in intensive-care settings due to their rapid action and lower resistance rates. The market is experiencing a revival spurred by increasing antimicrobial resistance, prompting healthcare professionals to explore aminoglycosides as part of combination therapies. Additionally, the demand for cost-effective treatment options in emerging economies has led to a push for generic formulations, enhancing accessibility while driving manufacturers to invest in high-quality production. Furthermore, AI-driven automation is optimizing drug discovery, formulation, and manufacturing processes, ultimately improving efficiency and delivery speeds. This dynamic environment fosters innovation and robust growth, ensuring the aminoglycosides market remains resilient.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aminoglycosides market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aminoglycosides Market Segments Analysis

Global aminoglycosides market is segmented by drug type, route of administration, application, end user, distribution channel and region. Based on drug type, the market is segmented into Gentamicin, Amikacin, Tobramycin, Streptomycin, Neomycin, Kanamycin, Paromomycin and Others. Based on route of administration, the market is segmented into Injectable, Oral, Topical and Inhalation. Based on application, the market is segmented into Gram-Negative Bacterial Infections, Tuberculosis, Respiratory Tract Infections, Urinary Tract Infections, Skin & Soft Tissue Infections, Gastrointestinal Infections and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare Settings and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aminoglycosides Market

The increasing dependence on aminoglycosides for treating severe bacterial infections in hospital environments propels market growth, as healthcare professionals emphasize the importance of broad-spectrum effectiveness and swift bactericidal properties. These antibiotics are particularly favored in intensive care units due to their reliable therapeutic results, where prompt infection management is essential. This heightened demand leads to an uptick in procurement by hospitals, encouraging manufacturers to enhance production capacity and invest in formulation advancements. This creates a continuous cycle that sustains demand across both well-established and developing healthcare sectors, further strengthening the market presence of aminoglycosides in regional hospitals and specialized clinics.

Restraints in the Global Aminoglycosides Market

The global aminoglycosides market faces significant challenges due to stringent regulatory frameworks that govern the approval process for new therapies. These regulations often result in prolonged review timelines and considerable compliance demands, which can discourage the introduction of new products. Manufacturers are required to undertake comprehensive preclinical and clinical studies to establish safety, particularly regarding concerns over nephrotoxicity and ototoxicity. This extensive research leads to higher development costs and delays in bringing innovations to market. Consequently, these obstacles restrict the availability of novel formulations, limit competition, and impede overall market expansion, especially as healthcare providers await validated treatments for vulnerable demographic groups.

Market Trends of the Global Aminoglycosides Market

The Global Aminoglycosides market is experiencing a significant surge driven by increased disposable incomes and enhanced insurance coverage in emerging economies. This trend is fueling the demand for injectable antibiotics, with aminoglycosides emerging as a cost-effective therapeutic solution. Concurrently, governments are prioritizing investments in healthcare infrastructure and antimicrobial acquisition, while local manufacturers are forging partnerships to boost production capacity. This convergence of supportive policies, streamlined supply chains, and a growing awareness of bacterial infections facilitates widespread adoption of aminoglycosides, fostering a robust growth trajectory that effectively counters the saturation seen in more mature markets across the globe.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Aminoglycosides Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Gentamicin
• Amikacin
• Tobramycin
• Streptomycin
• Neomycin
• Kanamycin
• Paromomycin
• Others

Global Aminoglycosides Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectable
• Oral
• Topical
• Inhalation

Global Aminoglycosides Market Size by Application & CAGR (2026-2033)

• Market Overview
• Gram-Negative Bacterial Infections
• Tuberculosis
• Respiratory Tract Infections
• Urinary Tract Infections
• Skin & Soft Tissue Infections
• Gastrointestinal Infections
• Others

Global Aminoglycosides Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Home Healthcare Settings
• Others

Global Aminoglycosides Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Aminoglycosides Market Size & CAGR (2026-2033)

• North America (Drug Type, Route of Administration, Application, End User, Distribution Channel)
  • US
  • Canada
• Europe (Drug Type, Route of Administration, Application, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Route of Administration, Application, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Route of Administration, Application, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Route of Administration, Application, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xellia Pharmaceuticals ApS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meiji Seika Pharma Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nichi-Iko Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspen Pharmacare Holdings Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taj Pharmaceuticals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alkem Laboratories Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wockhardt Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Serums and Vaccines Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire Aguettant SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations